177 related articles for article (PubMed ID: 12712215)
21. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
22. Current therapy for nonvariceal upper gastrointestinal bleeding.
Blocksom JM; Tokioka S; Sugawa C
Surg Endosc; 2004 Feb; 18(2):186-92. PubMed ID: 14625723
[TBL] [Abstract][Full Text] [Related]
23. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
[TBL] [Abstract][Full Text] [Related]
24. [Recent progress in the drug therapy for gastrointestinal bleeding].
Nakajima S; Bamba T
Nihon Rinsho; 1998 Sep; 56(9):2291-6. PubMed ID: 9780708
[TBL] [Abstract][Full Text] [Related]
25. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
Andriulli A; Annese V; Caruso N; Pilotto A; Accadia L; Niro AG; Quitadamo M; Merla A; Fiorella S; Leandro G
Am J Gastroenterol; 2005 Jan; 100(1):207-19. PubMed ID: 15654802
[TBL] [Abstract][Full Text] [Related]
26. Management of nonvariceal upper gastrointestinal bleeding.
Wee E
J Postgrad Med; 2011; 57(2):161-7. PubMed ID: 21654147
[TBL] [Abstract][Full Text] [Related]
27. Intravenous versus high-dose oral proton pump inhibitor therapy after endoscopic hemostasis of high-risk lesions in patients with acute nonvariceal upper gastrointestinal bleeding.
Murthy S; Keyvani L; Leeson S; Targownik LE
Dig Dis Sci; 2007 Jul; 52(7):1685-90. PubMed ID: 17385030
[TBL] [Abstract][Full Text] [Related]
28. Value of Oral Proton Pump Inhibitors in Acute, Nonvariceal Upper Gastrointestinal Bleeding: A Network Meta-Analysis.
Rodriguez EA; Donath E; Waljee AK; Sussman DA
J Clin Gastroenterol; 2017 Sep; 51(8):707-719. PubMed ID: 27505402
[TBL] [Abstract][Full Text] [Related]
29. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors for upper gastrointestinal bleeding.
Kherad O; Restellini S; Martel M; Barkun A
Best Pract Res Clin Gastroenterol; 2019; 42-43():101609. PubMed ID: 31785730
[TBL] [Abstract][Full Text] [Related]
31. Management of Upper Gastrointestinal Bleeding in Children: Variceal and Nonvariceal.
Lirio RA
Gastrointest Endosc Clin N Am; 2016 Jan; 26(1):63-73. PubMed ID: 26616897
[TBL] [Abstract][Full Text] [Related]
32. A Canadian clinical practice algorithm for the management of patients with nonvariceal upper gastrointestinal bleeding.
Barkun A; Fallone CA; Chiba N; Fishman M; Flook N; Martin J; Rostom A; Taylor A;
Can J Gastroenterol; 2004 Oct; 18(10):605-9. PubMed ID: 15497000
[TBL] [Abstract][Full Text] [Related]
33. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
Triadafilopoulos G
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
[TBL] [Abstract][Full Text] [Related]
34. A summary of recent recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.
Greenspoon J; Barkun A
Pol Arch Med Wewn; 2010 Sep; 120(9):341-6. PubMed ID: 20864907
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials.
Leontiadis GI; Sharma VK; Howden CW
Mayo Clin Proc; 2007 Mar; 82(3):286-96. PubMed ID: 17352364
[TBL] [Abstract][Full Text] [Related]
36. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
[TBL] [Abstract][Full Text] [Related]
37. Management of bleeding gastroduodenal ulcers.
Laursen SB; Jørgensen HS; Schaffalitzky de Muckadell OB;
Dan Med J; 2012 Jul; 59(7):C4473. PubMed ID: 22759855
[TBL] [Abstract][Full Text] [Related]
38. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
[TBL] [Abstract][Full Text] [Related]
39. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
40. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
